Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00234936
NCT00234936
View on ClinicalTrials.gov
Quality of Life Study With Adalimumab in Rheumatoid Arthritis
PHASE3
Completed
INTERVENTIONAL
Enrollment
200
Participants
Timeline
Start Date
December 31, 2003
Conditions
Rheumatoid Arthritis
Interventions
DRUG
Adalimumab
DRUG
Methotrexate
Sponsors
Lead Sponsor
Abbott
All Listed Sponsors
lead
Abbott
INDUSTRY
NCT00234936 - Quality of Life Study With Adalimumab in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter